Metraipolis › archive › dc_ad5e7d8025ed

Integrative Multi-Omics Analysis and Experiments Validation Identify COX5B as a Novel Therapeutic Target for Lung Adenocarcinoma — Europe PMC PMID:41502520

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41502520
DOI
10.32604/or.2025.069889
License (as archived)
solo-consultazione
Archived
2026-11-07T07:52:24.648Z
SHA-256 of the archived text
92669ca41ba9cfe2b0324262b6db0cca5c52fa885c8e09f5f4aa0029e1ff7268
Stable URL of this page
https://metraipolis.com/documento/dc_ad5e7d8025ed

How to cite

Integrative Multi-Omics Analysis and Experiments Validation Identify COX5B as a Novel Therapeutic Target for Lung Adenocarcinoma — Europe PMC PMID:41502520 — Europe PMC (en), https://europepmc.org/article/MED/41502520 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ad5e7d8025ed (Metraipolis archive dc_ad5e7d8025ed, sha256 92669ca41ba9cfe2b0324262b6db0cca5c52fa885c8e09f5f4aa0029e1ff7268)
BibTeX
@misc{dcad5e7d8025ed,
  title = {Integrative Multi-Omics Analysis and Experiments Validation Identify COX5B as a Novel Therapeutic Target for Lung Adenocarcinoma — Europe PMC PMID:41502520},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41502520},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ad5e7d8025ed; sha256 92669ca41ba9cfe2b0324262b6db0cca5c52fa885c8e09f5f4aa0029e1ff7268},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41502520. Agents can read the archived copy with the MCP tool read_document.